IFNAR1 and melanoma: The mean percentage of melanoma cells expressing IFNAR1 was 48.0 (± 29.5) in sections obtained before treatment with vemurafenib + PEG-IFN-α-2b, and 46.0 (± 19.5) in sections from post-treatment biopsies (Fig. 4).